TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 52 filers reported holding TYRA BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,186,140 | -20.5% | 1,393,329 | -1.7% | 2.31% | -32.2% |
| Q2 2023 | $24,131,476 | +6.0% | 1,416,998 | 0.0% | 3.40% | -13.1% |
| Q1 2023 | $22,771,158 | +111.4% | 1,416,998 | 0.0% | 3.92% | +129.3% |
| Q4 2022 | $10,769,185 | -13.5% | 1,416,998 | 0.0% | 1.71% | -22.0% |
| Q3 2022 | $12,455,000 | +22.9% | 1,416,998 | 0.0% | 2.19% | -5.6% |
| Q2 2022 | $10,132,000 | -26.3% | 1,416,998 | +10.3% | 2.32% | -28.7% |
| Q1 2022 | $13,749,000 | +51.4% | 1,284,990 | +99.1% | 3.25% | +8.6% |
| Q4 2021 | $9,080,000 | +3.4% | 645,349 | +29.3% | 2.99% | -6.2% |
| Q3 2021 | $8,778,000 | – | 499,040 | – | 3.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $60,725,576 | 53.26% |
| Nextech Invest Ltd. | 2,518,582 | $34,680,874 | 10.51% |
| Boxer Capital, LLC | 6,448,359 | $88,793,903 | 4.73% |
| TCG Crossover Management, LLC | 1,989,103 | $27,389,948 | 4.03% |
| Fairmount Funds Management LLC | 1,393,329 | $19,186,140 | 2.31% |
| RA Capital Management | 7,236,454 | $99,645,972 | 1.96% |
| 5AM Venture Management, LLC | 411,450 | $5,665,667 | 1.63% |
| BVF INC/IL | 2,739,595 | $37,724,223 | 1.02% |
| Frazier Life Sciences Management, L.P. | 1,028,013 | $14,155,739 | 0.94% |
| Auour Investments LLC | 85,020 | $1,198,782 | 0.51% |